TheraCryf plc, a clinical-stage drug developer focused on brain diseases, has released its full-year results for the year ending 31 March 2025.

03 Jun 2025
Final Results for year to 31 March 2025

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Final Results for year to 31 March 2025
TheraCryf PLC (TCF:LON) | 0.2 0 0.0% | Mkt Cap: 4.51m
- Published:
03 Jun 2025 -
Author:
Barry Gibb -
Pages:
6 -
TheraCryf plc, a clinical-stage drug developer focused on brain diseases, has released its full-year results for the year ending 31 March 2025.